FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Caplin Steriles Milrinone Lactate Injection Recall

Milrinone Lactate Injection, USP 20mg/20 mL (1mg/mL), packaged in 10 x 20 mL vials per…

Caplin Steriles Limited · Gummidipoondi, N/A

Risk level
Class III
Reported by FDA
Sep 13, 2023
Recall ID
D-1144-2023
Check your lot numberHow we source this data

Summary

Caplin Steriles recalled Milrinone Lactate Injection starting Aug 14, 2023. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1144-2023 on Sep 13, 2023. Reason: Failed Impurities/Degradation Specifications. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications

Product description

Milrinone Lactate Injection, USP 20mg/20 mL (1mg/mL), packaged in 10 x 20 mL vials per carton, NDC 72485-502-01 (single vial), Rx only, Distributed by: Armas Pharmaceuticals, Inc. Freehold, NJ 07728(USA) Manufactured by: Caplin Steriles Limited, India, NDC 72485-502-10

Lot numbers, UPCs & expiration codes

Lot #: 90000228

Where it was sold

Nationwide in Tennessee

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1144-2023
Classification
Class III
Status
Terminated
Recall initiated
Aug 14, 2023
FDA report date
Sep 13, 2023
Quantity
19, 820 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Caplin Steriles Limited

Original FDA data

Every field from FDA enforcement report D-1144-2023, exactly as published.

Show all FDA fields
City
Gummidipoondi
Status
Terminated
Country
India
Event ID
92900
Address
895 & 897 Survey No
Code information
Lot #: 90000228
Report date
Sep 13, 2023
Product type
Drugs
Recall number
D-1144-2023
Classification
Class III
Recalling firm
Caplin Steriles Limited
Product quantity
19, 820 vials
Termination date
Sep 9, 2025
Reason for recall
Failed Impurities/Degradation Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Milrinone Lactate Injection, USP 20mg/20 mL (1mg/mL), packaged in 10 x 20 mL vials per carton, NDC 72485-502-01 (single vial), Rx only, Distributed by: Armas Pharmaceuticals, Inc. Freehold, NJ 07728(USA) Manufactured by: Caplin Steriles Limited, India, NDC 72485-502-10
Distribution pattern
Nationwide in Tennessee
Recall initiation date
Aug 14, 2023
Initial firm notification
E-Mail
Center classification date
Sep 6, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1144-2023, published Sep 13, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls